{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:33:01Z","timestamp":1790281981630,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2025.06.045","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:57:06Z","timestamp":1750359426000},"page":"605-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Wound care\u2014Part II: Tissue-engineered skin substitutes and other advanced wound therapies"],"prefix":"10.1016","volume":"95","author":[{"given":"Fiona","family":"Haxho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1805-9994","authenticated-orcid":false,"given":"Yuliya","family":"Lytvyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Shelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.06.045_bib1","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/jps.21210","article-title":"Wound healing dressings and drug delivery systems: a review","volume":"97","author":"Boateng","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jaad.2025.06.045_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2133.1996.tb01164.x","article-title":"Skin grafts as pharmacological agents: pre-wounding of the donor site","volume":"135","author":"Kirsner","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2217\/rme-2022-0095","article-title":"Platelet-derived exosomes induce cell proliferation and wound healing in human endometrial cells","volume":"17","author":"Miller","year":"2022","journal-title":"Regen Med"},{"key":"10.1016\/j.jaad.2025.06.045_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/eurheartj\/ehz095","article-title":"Regeneration for all: an odyssey in biotherapy","volume":"40","author":"Behfar","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaad.2025.06.045_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1472-6963-9-115","article-title":"Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers","volume":"9","author":"Langer","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jaad.2025.06.045_bib6","doi-asserted-by":"crossref","first-page":"239s","DOI":"10.1097\/01.prs.0000222891.74489.33","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"117","author":"Sheehan","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.07.008","article-title":"Exosome-cargoed microRNAs: potential therapeutic molecules for diabetic wound healing","volume":"27","author":"Lou","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jaad.2025.06.045_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0092-8674(75)90183-X","article-title":"Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma","volume":"6","author":"Rheinwald","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2025.06.045_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/5584_2018_226","article-title":"Tissue engineered skin substitutes","volume":"1107","author":"Goodarzi","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaad.2025.06.045_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1056-8727(02)00218-0","article-title":"Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions: a pilot study","volume":"17","author":"Lobmann","year":"2003","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jaad.2025.06.045_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0142-9612(96)84670-9","article-title":"Quantitative assessment of the tissue response to films of hyaluronan derivatives","volume":"17","author":"Campoccia","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.jaad.2025.06.045_bib12","first-page":"274","article-title":"Factors that influence healing in chronic venous ulcers treated with cryopreserved human epidermal cultures","volume":"28","author":"Khachemoune","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/09546634.2018.1530443","article-title":"Skin substitutes for acute and chronic wound healing: an updated review","volume":"31","author":"Dai","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2025.06.045_bib14","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.2174\/1381612823666170526094606","article-title":"Tissue engineered skin and wound healing: current strategies and future directions","volume":"23","author":"Bhardwaj","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaad.2025.06.045_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/ijms18040789","article-title":"Advances in skin regeneration using tissue engineering","volume":"18","author":"Vig","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2025.06.045_bib16","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.3390\/ijms21218197","article-title":"From grafts to human bioengineered vascularized skin substitutes","volume":"21","author":"Oualla-Bachiri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2025.06.045_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.burns.2009.07.012","article-title":"Biological background of dermal substitutes","volume":"36","author":"van der Veen","year":"2010","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1203475416664037","article-title":"Current status and future of skin substitutes for chronic wound healing","volume":"21","author":"Nicholas","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/jispcd.JISPCD_359_16","article-title":"Human amnion membrane: potential applications in oral and periodontal field","volume":"7","author":"Mohan","year":"2017","journal-title":"J Int Soc Prev Community Dent"},{"key":"10.1016\/j.jaad.2025.06.045_bib20","doi-asserted-by":"crossref","first-page":"138S","DOI":"10.1097\/PRS.0000000000002643","article-title":"A review of cellular and acellular matrix products: indications, techniques, and outcomes","volume":"138","author":"Hughes","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00129334-200101000-00016","article-title":"Using skin replacement products to treat burns and wounds","volume":"14","author":"Hansen","year":"2001","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00004630-199701000-00008","article-title":"Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds","volume":"18","author":"Hansbrough","year":"1997","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.jaad.2025.06.045_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S0266462313000263","article-title":"Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis","volume":"29","author":"O'Reilly","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.burns.2007.03.020","article-title":"Bioengineered skin substitutes for the management of burns: a systematic review","volume":"33","author":"Pham","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0305-4179(00)00017-6","article-title":"The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group","volume":"26","author":"Waymack","year":"2000","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib26","article-title":"Skin grafting for venous leg ulcers","volume":"2013","author":"Jones","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2025.06.045_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archderm.134.3.293","article-title":"Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group","volume":"134","author":"Falanga","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1524-4725.1999.08186.x","article-title":"Acute excisional wounds treated with a tissue-engineered skin (Apligraf)","volume":"25","author":"Eaglstein","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archderm.136.10.1225","article-title":"Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds","volume":"136","author":"Falabella","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2230.2001.00789.x","article-title":"Tissue-engineered dermal skin grafting in the treatment of ulcerated necrobiosis lipoidica","volume":"26","author":"Owen","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1054\/bjps.1998.9997","article-title":"Surgical management of hands in children with recessive dystrophic epidermolysis bullosa: use of allogeneic composite cultured skin grafts","volume":"51","author":"Eisenberg","year":"1998","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0305-4179(03)00164-5","article-title":"The use of a collagen sponge\/living cell composite material to treat donor sites in burn patients","volume":"29","author":"Still","year":"2003","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0733-8635(05)70295-3","article-title":"Use of skin substitutes in dermatology","volume":"19","author":"Bello","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2025.06.045_bib34","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/PRS.0000000000001748","article-title":"Tissue-engineered skin substitutes","volume":"136","author":"Nyame","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib35","first-page":"1","article-title":"Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers: a health technology assessment","volume":"21","author":"Ontario","year":"2021","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.jaad.2025.06.045_bib36","series-title":"Skin Substitutes for Treating Chronic Wounds","author":"Snyder","year":"2020"},{"key":"10.1016\/j.jaad.2025.06.045_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/iwj.12600","article-title":"A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers","volume":"14","author":"Zelen","year":"2017","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12434","article-title":"Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: highlights of a Cochrane systematic review","volume":"24","author":"Santema","year":"2016","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib39","article-title":"Skin grafting and tissue replacement for treating foot ulcers in people with diabetes","volume":"2","author":"Santema","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2025.06.045_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/iwj.12566","article-title":"Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost","volume":"13","author":"Zelen","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib42","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/iwj.13094","article-title":"Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion\/chorion membrane allograft","volume":"16","author":"Bianchi","year":"2019","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/iwj.12843","article-title":"A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion\/chorion membrane (EpiFix((R))) allograft for the treatment of venous leg ulcers","volume":"15","author":"Bianchi","year":"2018","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/wrr.12227","article-title":"A multicenter, randomized, controlled clinical trial evaluating the use of dehydrated human amnion\/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers","volume":"22","author":"Serena","year":"2014","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/iwj.12053","article-title":"A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers","volume":"10","author":"Harding","year":"2013","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jvs.2005.01.042","article-title":"Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial","volume":"41","author":"Mostow","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cpm.2018.02.006","article-title":"Randomized, prospective, blinded-enrollment, head-to-head venous leg ulcer healing trial comparing living, bioengineered skin graft substitute (Apligraf) with living, cryopreserved, human skin allograft (TheraSkin)","volume":"35","author":"Towler","year":"2018","journal-title":"Clin Podiatr Med Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jtv.2018.11.001","article-title":"An extracellular matrix graft (Oasis((R)) wound matrix) for treating full-thickness pressure ulcers: a randomized clinical trial","volume":"28","author":"Brown-Etris","year":"2019","journal-title":"J Tissue Viability"},{"key":"10.1016\/j.jaad.2025.06.045_bib60","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1742-481X.2011.00859.x","article-title":"Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds","volume":"8","author":"Upton","year":"2011","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib61","first-page":"515","article-title":"Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds","volume":"6","author":"Herouy","year":"2000","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaad.2025.06.045_bib62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2337\/diacare.21.5.822","article-title":"Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study","volume":"21","author":"Wieman","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.ASW.0000392922.30229.b3","article-title":"A matched cohort study of the risk of cancer in users of becaplermin","volume":"24","author":"Ziyadeh","year":"2011","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00129334-200506000-00012","article-title":"Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers","volume":"18","author":"Niezgoda","year":"2005","journal-title":"Adv Skin Wound Care"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2025.06.045_bib65","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1529-8019.2008.00196.x","article-title":"Treatment of chronic venous leg ulcers by platelet gel","volume":"21","author":"Ficarelli","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2025.06.045_bib66","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/09546634.2012.735637","article-title":"Treatment of refractory venous stasis ulcers with autologous platelet-rich plasma and light-emitting diodes: a pilot study","volume":"24","author":"Park","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2025.06.045_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.ASW.0000403249.85131.6f","article-title":"The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel","volume":"24","author":"de Leon","year":"2011","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib68","first-page":"36","article-title":"Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series","volume":"56","author":"Frykberg","year":"2010","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.jaad.2025.06.045_bib69","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/wrr.12443","article-title":"The application of platelet-rich plasma in the treatment of deep dermal burns: a randomized, double-blind, intra-patient controlled study","volume":"24","author":"Marck","year":"2016","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib70","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1524-475X.2008.00426.x","article-title":"Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers","volume":"16","author":"O'Connell","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib71","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2213-8587(18)30240-7","article-title":"LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial","volume":"6","author":"Game","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jaad.2025.06.045_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2005.06925.x","article-title":"Granulocyte\/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed","volume":"154","author":"Cianfarani","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1479-5876-6-75","article-title":"Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF","volume":"6","author":"Brem","year":"2008","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaad.2025.06.045_bib74","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.4238\/2015.March.31.3","article-title":"Safety of recombinant human granulocyte-macrophage colony-stimulating factor in healing pediatric severe burns","volume":"14","author":"Chi","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jaad.2025.06.045_bib75","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.burns.2014.12.004","article-title":"Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn","volume":"41","author":"Yuan","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib76","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10016-006-9036-9","article-title":"Venous ulcer fibroblasts respond to basic fibroblast growth factor at the cell cycle protein level","volume":"20","author":"Seidman","year":"2006","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib77","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2009.0750","article-title":"Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer","volume":"19","author":"Uchi","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1524-475X.2008.00414.x","article-title":"Basic fibroblast growth factor accelerates and improves second-degree burn wound healing","volume":"16","author":"Akita","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00006534-199801000-00015","article-title":"Venous ulcers: improved healing by iontophoretic administration of calcitonin gene-related peptide and vasoactive intestinal polypeptide","volume":"101","author":"Gherardini","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib49","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM198511283132205","article-title":"Burns","volume":"313","author":"Demling","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.06.045_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004630-199505000-00018","article-title":"Use of Biobrane in wound management","volume":"16","author":"Smith","year":"1995","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.jaad.2025.06.045_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0305-4179(89)90183-6","article-title":"Clinical comparison of commercially available Biobrane preparations","volume":"15","author":"Yang","year":"1989","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib52","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bjps.2008.01.014","article-title":"Permanent scarring in a partial thickness scald burn dressed with Biobrane","volume":"62","author":"Ahmadi","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib53","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/00005373-198808000-00022","article-title":"Biosynthetic skin substitute vs. 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns","volume":"28","author":"Gerding","year":"1988","journal-title":"J Trauma"},{"key":"10.1016\/j.jaad.2025.06.045_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-481X.2006.00279.x","article-title":"Paediatric partial-thickness scald burns\u2013is Biobrane the best treatment available?","volume":"4","author":"Mandal","year":"2007","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/SAP.0b013e31806bf446","article-title":"A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon","volume":"60","author":"Whitaker","year":"2008","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00000658-198809000-00008","article-title":"Artificial dermis for major burns. A multi-center randomized clinical trial","volume":"208","author":"Heimbach","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000658-198110000-00005","article-title":"Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury","volume":"194","author":"Burke","year":"1981","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.burns.2007.01.018","article-title":"The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns--a pilot study","volume":"34","author":"Ryssel","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.burns.2008.07.018","article-title":"Matriderm versus Integra: a comparative experimental study","volume":"35","author":"Schneider","year":"2009","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102105","article-title":"Incisional negative pressure wound therapy for the prevention of surgical site infection: an up-to-date meta-analysis and trial sequential analysis","volume":"62","author":"Groenen","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaad.2025.06.045_bib81","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/iwj.14072","article-title":"Effects of negative pressure wound therapy with instillation and dwell time (NPWTi-d) versus NPWT or standard of care in orthoplastic surgery: a systematic review and meta-analysis","volume":"20","author":"De Pellegrin","year":"2023","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2025.06.045_bib82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2023.07.1031","article-title":"A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis","volume":"90","author":"Biglione","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.06.045_bib86","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ultrasmedbio.2008.01.010","article-title":"Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities","volume":"34","author":"Saggini","year":"2008","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jaad.2025.06.045_bib87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2474-10-54","article-title":"The management of neuropathic ulcers of the foot in diabetes by shock wave therapy","volume":"10","author":"Moretti","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jaad.2025.06.045_bib88","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.diabres.2014.09.024","article-title":"Efficacy of shock wave therapy on chronic diabetic foot ulcer: a single-blinded randomized controlled clinical trial","volume":"106","author":"Omar","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jaad.2025.06.045_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijsu.2015.06.024","article-title":"Extracorporeal shockwave therapy in diabetic foot ulcers","volume":"24","author":"Wang","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib90","doi-asserted-by":"crossref","first-page":"641","DOI":"10.12968\/jowc.2016.25.11.641","article-title":"Extracorporeal shockwave therapy in the treatment of chronic diabetic foot ulcers: a prospective randomised trial","volume":"25","author":"Jeppesen","year":"2016","journal-title":"J Wound Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib91","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1524-475X.2011.00701.x","article-title":"Noncontact low-frequency ultrasound therapy in the treatment of chronic wounds: a meta-analysis","volume":"19","author":"Driver","year":"2011","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib92","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/lsm.20789","article-title":"Phototherapy promotes healing of chronic diabetic leg ulcers that failed to respond to other therapies","volume":"41","author":"Minatel","year":"2009","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2025.06.045_bib93","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/pho.2010.2858","article-title":"Visible light-induced healing of diabetic or venous foot ulcers: a placebo-controlled double-blind study","volume":"29","author":"Landau","year":"2011","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/pho.2009.2680","article-title":"A randomized clinical trial on the effect of low-level laser therapy on chronic diabetic foot wound healing: a preliminary report","volume":"29","author":"Kaviani","year":"2011","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib95","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12262-011-0393-4","article-title":"Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers-a randomised control trial","volume":"74","author":"Kajagar","year":"2012","journal-title":"Indian J Surg"},{"key":"10.1016\/j.jaad.2025.06.045_bib96","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/wrr.12399","article-title":"A systematic review of low-level light therapy for treatment of diabetic foot ulcer","volume":"24","author":"Tchanque-Fossuo","year":"2016","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2025.06.045_bib97","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13287-017-0683-2","article-title":"Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells","volume":"8","author":"Guo","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jaad.2025.06.045_bib98","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/db18-0699","article-title":"Potential of allogeneic adipose-derived stem cell-hydrogel complex for treating diabetic foot ulcers","volume":"68","author":"Moon","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jaad.2025.06.045_bib99","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1179\/2045772311Y.0000000010","article-title":"Treatment of pressure ulcers with autologous bone marrow nuclear cells in patients with spinal cord injury","volume":"34","author":"Sarasua","year":"2011","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.jaad.2025.06.045_bib100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/mi12040430","article-title":"Wearable sensors and systems for wound healing-related pH and temperature detection","volume":"12","author":"Tang","year":"2021","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.jaad.2025.06.045_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASW.0000725188.95109.68","article-title":"Smart dressings for wound healing: a review","volume":"34","author":"Barros Almeida","year":"2021","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jaad.2025.06.045_bib102","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/acsabm.8b00637","article-title":"Latest progress in electrospun Nanofibers for wound healing applications","volume":"2","author":"Memic","year":"2019","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.jaad.2025.06.045_bib103","article-title":"Natural polymer-based scaffolds for soft tissue repair","volume":"10","author":"Chen","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jaad.2025.06.045_bib83","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.burns.2012.02.001","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds","volume":"38","author":"Yan","year":"2012","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2025.06.045_bib84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2013.01.027","article-title":"A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds","volume":"444","author":"Heilmann","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaad.2025.06.045_bib85","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/09205063.2012.718613","article-title":"Sequential antibiotic and growth factor releasing chitosan-PAAm semi-IPN hydrogel as a novel wound dressing","volume":"24","author":"Pulat","year":"2013","journal-title":"J Biomater Sci Polym Ed"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:38:22Z","timestamp":1787139502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225023758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0190962225023758"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.045","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wound care\u2014Part II: Tissue-engineered skin substitutes and other advanced wound therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(26)03116-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.103","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}